CEFXOBEES-S-375: Powerful Ceftriaxone 250 mg + Sulbactam 125 mg Injection for Enhanced Antibacterial Protection

Introduction

CEFXOBEES-S-375 is an advanced broad-spectrum antibacterial injection from Amcare Biosciences, formulated to deliver superior clinical outcomes in moderate bacterial infections.
This dual-strength combination contains:

• Ceftriaxone Sodium IP (sterile) equivalent to Anhydrous Ceftriaxone 250 mg

• Sulbactam Sodium IP equivalent to Anhydrous Sulbactam 125 mg

The synergistic action of Ceftriaxone and Sulbactam enhances antibacterial potency, overcomes resistance, and ensures faster therapeutic response.
As part of the trusted CEFXOBEES antibiotic family, CEFXOBEES-S-375 ensures unmatched purity, safety, and reliability.

What is CEFXOBEES-S-375?

1. Ceftriaxone Sodium IP

Equivalent to Anhydrous Ceftriaxone 250 mg

• A potent 3rd-generation cephalosporin

• Inhibits bacterial cell wall synthesis

• Active against a wide spectrum of gram-positive & gram-negative bacteria

• Effective in respiratory, urinary, abdominal, skin, and systemic infections

• Forms the core antibacterial component of the CEFXOBEES series

2. Sulbactam Sodium IP

Equivalent to Anhydrous Sulbactam 125 mg

• A powerful β-lactamase inhibitor

• Protects Ceftriaxone from enzyme-mediated resistance

• Enhances penetration and potency against resistant bacteria

• Broadens the antibacterial spectrum

Key Benefits of CEFXOBEES-S-375

✔ Broad-spectrum antibacterial effectiveness
✔ Strong activity against β-lactamase–producing organisms
✔ Faster recovery and better symptom resolution
✔ Suitable for mild to moderate infections
✔ Manufactured under strict IP sterile standards
✔ Trusted formulation within the CEFXOBEES product range

Indications

CEFXOBEES-S-375 is commonly used for:

• Respiratory tract infections

• Urinary tract infections (UTIs)

• Skin & soft tissue infections

• Intra-abdominal infections

• Gynecological infections

• Bone & joint infections

• Early-stage bloodstream infections

• Post-operative infections

How CEFXOBEES-S-375 Works

Ceftriaxone 250 mg

• Inhibits bacterial cell wall synthesis

• Prevents bacterial growth & replication

• Effective against major clinical pathogens

Sulbactam 125 mg

• Blocks β-lactamase enzymes

• Prevents Ceftriaxone degradation

• Enhances and widens antibacterial coverage

Together, they ensure rapid, reliable, and long-lasting infection control.

Possible Side Effects

Common:

• Mild injection site pain

• Diarrhea

• Nausea

• Mild rash

Rare:

• Allergy or hypersensitivity

• Severe diarrhea

• Elevated liver enzymes

Note: Use strictly under medical supervision.

Amcare Biosciences – Leading PCD Pharma Company in Gujarat

Amcare Biosciences is a fast-growing and reliable PCD Pharma Company in Gujarat, offering a wide range of pharmaceutical, ayurvedic, nutraceutical, and cosmetic formulations across India.
Our trusted brands—CEFXOBEES-S-375, CEFXOBEES-1 GM, CILNIBIL series, LINABEES series, and EMPAWITH series—reflect our commitment to quality and therapeutic excellence.

We also provide profitable PCD Pharma Franchise opportunities, helping partners build sustainable and stable businesses.

Conclusion

CEFXOBEES-S-375, combining Ceftriaxone 250 mg and Sulbactam 125 mg, delivers powerful and dependable antibacterial activity.
Backed by the superior quality standards of Amcare Biosciences, it ensures fast recovery, broad antibacterial protection, and enhanced clinical outcomes in patients with bacterial infections.